As expected, both arecoline treatment (low concentration) and HPV16 E6/E7 could induce PRDX2 overexpression in oral cell lines including oral cancer (ORL-48T and ORL-136T) and immortalized tongue keratinocyte (HTK1T-KTD4) cell lines. The gene discussed is PRDX2; the disease is lip and oral cavity carcinoma.